Preventing HPV-related Disease: What Do the Latest Data Tell Us?

Slides:

Advertisements

Similar presentations

2010 National Immunization Survey Report, Texas Child and Teen Vaccination Coverage Levels Jack Sims-Immunization Branch Manager Tony Aragon, MS-Epidemiologist.

Advertisements

ACIP Meeting Update November 4 th

HPV Vaccine Update Eileen Yamada, MD, MPH Immunization Branch California Department of Health Services.

You are the Key to HPV Cancer Prevention Understanding the Burden of HPV Disease, the Importance of the HPV Vaccine Recommendation, and Communicating about.

Anticipated impact on HPV infection from HPV vaccination programs – cause for optimism Dr Paddy Horner.

HPV Related Disease Ginny Ryan. What Is HPV? The human papillomavirus is the most common sexually transmitted infection in the U.S. – 79 million Americans.

Mass Media’s Portrayal of HPV Vaccination among Adolescent Males in Online News Content: A Framing Analysis Gabrielle Darville, MPH 1, Whitney D. Smith.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

Progress in adolescent vaccination coverage levels in the United States National Immunization Conference Washington, DC March 31, 2011 Shannon Stokley,

Position on HPV vaccinesAvailable from In July 2013, The Global Advisory Committee on Vaccine Safety (GACVS) of the WHO reconfirmed that there had been.

“Take the Test: Not the Risk” HPV and Cervical Cancer Cervical Cancer is Preventable!

An Examination of HPV Vaccine Administration in Georgia

QUALITY IMPROVEMENT FOR HPV VACCINATION

HPV Vaccine is Cancer Prevention

Demographics of Parents

Making Effective HPV Vaccine Recommendations

Cancers Linked to HPV Presenter: Chuck Lynch

Copyright © 2015 by the American Osteopathic Association.

© I.M.Quizitor Pediatrics Date.

Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP

Annie-Laurie McRee, DrPH, Melissa B. Gilkey, PhD, Amanda F

HPV Vaccines and Data Needed for Development of Recommendations in the United States Lauri E. Markowitz, MD Centers for Disease Control and Prevention.

Human Papillomavirus (HPV)

Wenbo Li, Yan Jin, Glen Nowak

Vaccination Rates in Idaho: Updates Fall 2017

Back to School 2013: An Immunization Checklist

10 Things You Should Know About HPV

Christina Dorell, MD, MPH

Dengue Prevention in Asia

The Current HPV Vaccination Landscape and Emerging Opportunities

Ten Years of Human Papillomavirus Vaccination in the United States

Implementation Issues for HPV Vaccine

HPV-Related Disease: Separating Fact From Fiction

Adult Immunization: Making the Most of Everyday Opportunities

DENGUE VACCINE.

Pertussis disease: regional perspectives

Immunizing the Older Adult: Challenges and Opportunities

ACIP Recommended Vaccines for Adults – By Age

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Estimated Vaccination Coverage Among Adolescents Aged Years

Immunization Against Varicella:

The State of Pneumococcal Disease Prevention

Understanding PAD.

10 Things You Should Know About HPV

HPV VACCINATION FOR CANCER PREVENTION: Progress, Opportunities, and a Renewed Call to Action A Report to the President of the United States from the Chair.

Increasing Adolescent Immunization Coverage

Maternal Pertussis vaccination: Giving Newborns a head start

Treatment of Thromboembolic Disease The Need for Multiple Perspectives

Serogroup B Meningococcal Disease

National Gains If All States Achieved Top Rates* of Performance

Coverage Rates in Texas

Battling the Flu: Latest Advances in the Influenza Treatment Arsenal

Preventing Meningococcal B Disease

IBD Increases Risk for Vaccine-Preventable Diseases

Exercise Provider Hesitant Parent

National gains if all states achieved top rates* of performance

Immunization Throughout the Life Course: What Is the Clinician's Role?

Adolescent and Adult ACIP Update

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.

Prioritizing Prevention of HPV-Related Disease

Martha A. Wojtowycz, PhD March 22, 2019

Melinda Wharton, MD, MPH Director, Immunization Services Division

Distilling the Data: The Latest Updates on HPV-Related Disease and Its Prevention.

NoelleAngelique M. Molinari, PhD Nidhi Jain, MD CDC

Adjusted rate ratios for individual autoimmune disorders diagnosed in the 7–60 days after quadrivalent human papillomavirus (HPV4) vaccination. *Autoimmune.

Megan Masters, MSN Candidate DePaul University School of Nursing

Karen A. Cullen, Diana L. Bartlett, C. Robinette Curtis

Presentation transcript:

Preventing HPV-related Disease: What Do the Latest Data Tell Us?

Goals

Indications for HPV Immunization: Quadrivalent Vaccine

Indications for HPV Immunization: Bivalent Vaccine

More Recently Approved Indications

ACIPa and AAPb Recommendations

Safety and Cost-Effectiveness of HPV Vaccines

Estimated Vaccination Coverage Among US Adolescents Age 13-17 Years, National Immunization Survey-Teen, 2011

HPV-related Cancers

Indications for HPV Immunization in Males

Findings From 2012 International Papillomavirus Conference (IPC)

Findings From 2012 IPC (cont)

Efficacy of HPV Immunization in Australia

Efficacy of HPV Immunization in Denmark

Efficacy of HPV Immunization in Denmark (cont)

Herd Immunity

Strategies for Improving HPV Immunization Rates

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)